Skip to content

Effect of Vidangadi Nasya in Ardhavbhedaka(Migraine).

A randomised controlled clinical trail to study the effect of vidangadi nasya in ardhavahedaka with special reference to simple migraine. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072244
Enrollment
62
Registered
2024-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Sponsors

Dr Swarada Gadekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients having the cardinal features of Ardhavabhedaka (Migraine without aura) b) Patients aged between 18-60 years. c) Patients will be included irrespective of sex, religion and caste. d) Patients fit for Nasya Karma.

Exclusion criteria

Exclusion criteria: a) Patients having a history of head trauma and other types of headaches. b) Patients having any inflammatory diseases in nose ,PNS ,eyes and ears. c) Patients with other systemic disorder’s like hypertention ,diabetes mellitus etc.

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms of Ardhavabhedaka after administration of Vidangadi nasyaTimepoint: 7 days

Secondary

MeasureTime frame
Where the trial group stands in comparison with control groupTimepoint: 18 months

Countries

India

Contacts

Public ContactDr Swarada Ashok Gadekar

SMBT Ayurved College and Hospital

petalsayu@gmail.com9850447661

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026